Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955572521> ?p ?o ?g. }
- W2955572521 endingPage "3370" @default.
- W2955572521 startingPage "3356" @default.
- W2955572521 abstract "Purpose Dose conformality and robustness are equally important in intensity modulated proton therapy (IMPT). Despite the obvious implication of beam orientation on both dosimetry and robustness, an automated, robust beam orientation optimization algorithm has not been incorporated due to the problem complexity and paramount computational challenge. In this study, we developed a novel IMPT framework that integrates robust beam orientation optimization (BOO) and robust fluence map optimization (FMO) in a unified framework. Methods The unified framework is formulated to include a dose fidelity term, a heterogeneity‐weighted group sparsity term, and a sensitivity regularization term. The L2, 1/2‐norm group sparsity is used to reduce the number of active beams from the initial 1162 evenly distributed noncoplanar candidate beams, to between two and four. A heterogeneity index, which evaluates the lateral tissue heterogeneity of a beam, is used to weigh the group sparsity term. With this index, beams more resilient to setup uncertainties are encouraged. There is a symbiotic relationship between the heterogeneity index and the sensitivity regularization; the integrated optimization framework further improves beam robustness against both range and setup uncertainties. This S ensitivity regularization and H eterogeneity weighting based BOO and FMO framework (SHBOO‐FMO) was tested on two skull‐base tumor (SBT) patients and two bilateral head‐and‐neck (H&N) patients. The conventional CTV‐based optimized plans (Conv) with SHBOO‐FMO beams (SHBOO‐Conv) and manual beams (MAN‐Conv) were compared to investigate the beam robustness of the proposed method. The dosimetry and robustness of SHBOO‐FMO plan were compared against the manual beam plan with CTV‐based voxel‐wise worst‐case scenario approach (MAN‐WC). Results With SHBOO‐FMO method, the beams with superior range robustness over manual beams were selected while the setup robustness was maintained or improved. On average, the lowest [D95%, V95%, V100%] of CTV were increased from [93.85%, 91.06%, 70.64%] in MAN‐Conv plans, to [98.62%, 98.61%, 96.17%] in SHBOO‐Conv plans with range uncertainties. With setup uncertainties, the average lowest [D98%, D95%, V95%, V100%] of CTV were increased from [92.06%, 94.83%, 94.31%, 78.93%] in MAN‐Conv plans, to [93.54%, 96.61%, 97.01%, 91.98%] in SHBOO‐Conv plans. Compared with the MAN‐WC plans, the final SHBOO‐FMO plans achieved comparable plan robustness and better OAR sparing, with an average reduction of [Dmean, Dmax] of [6.31, 6.55] GyRBE for the SBT cases and [1.89, 5.08] GyRBE for the H&N cases from the MAN‐WC plans. Conclusion We developed a novel method to integrate robust BOO and robust FMO into IMPT optimization for a unified solution of both BOO and FMO, generating plans with superior dosimetry and good robustness." @default.
- W2955572521 created "2019-07-12" @default.
- W2955572521 creator A5026938414 @default.
- W2955572521 creator A5051178027 @default.
- W2955572521 creator A5051265222 @default.
- W2955572521 creator A5056932023 @default.
- W2955572521 creator A5080815829 @default.
- W2955572521 creator A5090002307 @default.
- W2955572521 date "2019-06-26" @default.
- W2955572521 modified "2023-10-14" @default.
- W2955572521 title "Robust beam orientation optimization for intensity‐modulated proton therapy" @default.
- W2955572521 cites W1577853441 @default.
- W2955572521 cites W1983869432 @default.
- W2955572521 cites W1989466856 @default.
- W2955572521 cites W1994053519 @default.
- W2955572521 cites W2004233638 @default.
- W2955572521 cites W2006626394 @default.
- W2955572521 cites W2007510360 @default.
- W2955572521 cites W2008122313 @default.
- W2955572521 cites W2010851248 @default.
- W2955572521 cites W2011307344 @default.
- W2955572521 cites W2012457048 @default.
- W2955572521 cites W2016185232 @default.
- W2955572521 cites W2029775895 @default.
- W2955572521 cites W2035306925 @default.
- W2955572521 cites W2045952621 @default.
- W2955572521 cites W2053700561 @default.
- W2955572521 cites W2054860593 @default.
- W2955572521 cites W2055233491 @default.
- W2955572521 cites W2056559285 @default.
- W2955572521 cites W2060625002 @default.
- W2955572521 cites W2060740081 @default.
- W2955572521 cites W2062379060 @default.
- W2955572521 cites W2063414481 @default.
- W2955572521 cites W2063903585 @default.
- W2955572521 cites W2064712772 @default.
- W2955572521 cites W2066648318 @default.
- W2955572521 cites W2070916900 @default.
- W2955572521 cites W2075833875 @default.
- W2955572521 cites W2076014710 @default.
- W2955572521 cites W2080126859 @default.
- W2955572521 cites W2086479790 @default.
- W2955572521 cites W2092515499 @default.
- W2955572521 cites W2100556411 @default.
- W2955572521 cites W2102192086 @default.
- W2955572521 cites W2103101993 @default.
- W2955572521 cites W2107667490 @default.
- W2955572521 cites W2284035059 @default.
- W2955572521 cites W2329205749 @default.
- W2955572521 cites W2336899457 @default.
- W2955572521 cites W2383496628 @default.
- W2955572521 cites W2520116834 @default.
- W2955572521 cites W2554955264 @default.
- W2955572521 cites W2604380817 @default.
- W2955572521 cites W2790425179 @default.
- W2955572521 cites W2894964113 @default.
- W2955572521 cites W2905689821 @default.
- W2955572521 cites W3103396062 @default.
- W2955572521 cites W3104581781 @default.
- W2955572521 cites W96354403 @default.
- W2955572521 doi "https://doi.org/10.1002/mp.13641" @default.
- W2955572521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6692214" @default.
- W2955572521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31169917" @default.
- W2955572521 hasPublicationYear "2019" @default.
- W2955572521 type Work @default.
- W2955572521 sameAs 2955572521 @default.
- W2955572521 citedByCount "25" @default.
- W2955572521 countsByYear W29555725212020 @default.
- W2955572521 countsByYear W29555725212021 @default.
- W2955572521 countsByYear W29555725212022 @default.
- W2955572521 countsByYear W29555725212023 @default.
- W2955572521 crossrefType "journal-article" @default.
- W2955572521 hasAuthorship W2955572521A5026938414 @default.
- W2955572521 hasAuthorship W2955572521A5051178027 @default.
- W2955572521 hasAuthorship W2955572521A5051265222 @default.
- W2955572521 hasAuthorship W2955572521A5056932023 @default.
- W2955572521 hasAuthorship W2955572521A5080815829 @default.
- W2955572521 hasAuthorship W2955572521A5090002307 @default.
- W2955572521 hasBestOaLocation W29555725211 @default.
- W2955572521 hasConcept C104317684 @default.
- W2955572521 hasConcept C120665830 @default.
- W2955572521 hasConcept C121332964 @default.
- W2955572521 hasConcept C126255220 @default.
- W2955572521 hasConcept C168834538 @default.
- W2955572521 hasConcept C183115368 @default.
- W2955572521 hasConcept C185592680 @default.
- W2955572521 hasConcept C193254401 @default.
- W2955572521 hasConcept C24890656 @default.
- W2955572521 hasConcept C2779244869 @default.
- W2955572521 hasConcept C2989005 @default.
- W2955572521 hasConcept C33923547 @default.
- W2955572521 hasConcept C41008148 @default.
- W2955572521 hasConcept C55493867 @default.
- W2955572521 hasConcept C63479239 @default.
- W2955572521 hasConcept C71924100 @default.
- W2955572521 hasConcept C75088862 @default.
- W2955572521 hasConceptScore W2955572521C104317684 @default.
- W2955572521 hasConceptScore W2955572521C120665830 @default.